Back to Journals » Psychology Research and Behavior Management » Volume 12

Exposure and Response Prevention in the Treatment of Obsessive-Compulsive Disorder: Current Perspectives

Authors Law C, Boisseau CL

Received 6 November 2019

Accepted for publication 17 December 2019

Published 24 December 2019 Volume 2019:12 Pages 1167—1174

DOI https://doi.org/10.2147/PRBM.S211117

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Igor Elman


Clara Law, Christina L Boisseau

Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Correspondence: Christina L Boisseau
Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, 710 N. Lake Shore Drive Suite, Chicago, IL 1223, USA
Tel +1 312-530-3270
Email christina.boisseau@northwestern.edu

Abstract: Numerous clinical trials support the efficacy of exposure and response prevention (ERP) for the treatment of obsessive-compulsive disorder (OCD). Accordingly, ERP has been formally recognized as a first-line, evidence-based treatment for OCD. This review discusses the theoretical underpinnings of the treatment from a behavioral and neurobiological perspective and summarizes the evidence supporting the efficacy of ERP across child and adult populations. Next, we discuss predictors of ERP treatment outcome and discuss implementation strategies designed to improve feasibility and adoption. Finally, strategies to improve treatment dissemination are discussed.

Keywords: extinction, learning, rituals, behavior, treatment

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]